OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
124 hedge funds and large institutions have $467M invested in Orexigen Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 39 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
Holders
124
Holding in Top 10
–
Calls
$11.3M
Puts
$7.62M
Top Buyers
| 1 | +$21.6M | |
| 2 | +$18.6M | |
| 3 | +$12.4M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$8.24M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$6.01M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$12.9M | |
| 3 | -$7.19M | |
| 4 |
Jennison Associates
New York
|
-$5.13M |
| 5 |
PC
Passport Capital
San Francisco,
California
|
-$4.6M |